AndrewLeoSochackiMD

PubMed

• 1 citations
  Driver mutation zygosity is a critical factor in predicting clonal hematopoiesis transformation risk.
  Ashwin Kishtagari, M A Wasay Khan, Yajing Li, Caitlyn Vlasschaert, Naimisha Marneni, Alexander J Silver, Kelly von Beck, Travis Spaulding, Shannon Stockton, Christina ...> ;Blood Cancer Journal. 2024 Jan 15
• 37 citations
  Mutational landscape of myelodysplastic/myeloproliferative neoplasm–unclassifiable
  Prithviraj Bose, Aziz Nazha, Rami S. Komrokji, Keyur P. Patel, Sherry Pierce, Najla Alali, Andrew Sochacki, Aaron C. Shaver, Wencai Ma, Xiaoping Su, Naval Daver, Court...> ;Blood. 2018 Nov 8
• 5 citations
  Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes.
  Andrew Sochacki, Melissa A. Fischer, Michael R. Savona> ;Oncotargets and Therapy. 2016 Apr 15
• 67 citations
  N-3 polyunsaturated Fatty acids prevent diabetic retinopathy by inhibition of retinal vascular damage and enhanced endothelial progenitor cell reparative function.
  Maria Tikhonenko, Todd A. Lydic, Madalina Opreanu, Sergio Li Calzi, Svetlana N. Bozack, Kelly M. McSorley, Andrew L. Sochacki, Matthew S. Faber, Sugata Hazra, Shane Du...> ;Plos One. 2013 Jan 29
• 71 citations
  The Unconventional Role of Acid Sphingomyelinase in Regulation of Retinal Microangiopathy in Diabetic Human and Animal Models
  Madalina Opreanu, Maria Tikhonenko, Svetlana N. Bozack, Todd A. Lydic, Gavin E. Reid, Kelly M. McSorley, Andrew L. Sochacki, Gloria I. Perez, Walter J. Esselman, Timot...> ;Diabetes. 2011 Sep 1
• 102 citations
  Remodeling of Retinal Fatty Acids in an Animal Model of Diabetes: A Decrease in Long-Chain Polyunsaturated Fatty Acids Is Associated With a Decrease in Fatty Acid Elon...
  Maria Tikhonenko, Todd A. Lydic, Yun Wang, Weiqin Chen, Madalina Opreanu, Andrew L. Sochacki, Kelly M. McSorley, Rebecca L. Renis, Timothy S. Kern, Donald B. Jump, Gav...> ;Diabetes. 2010 Jan 1
• 185 citations
  Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock.
  Julia V. Busik, Maria Tikhonenko, Ashay D Bhatwadekar, Madalina Opreanu, Nafissa Yakubova, Sergio Caballero, Danny Player, Takahiko Nakagawa, Aqeela Afzal, Jennifer L....> ;The Journal of Experimental Medicine. 2009 Dec 21
• Join now to see all

Journal Articles

• Mutational Landscape of myelodysplastic/myeloproliferative Neoplasm – Unclassifiable (MDS/MPN-U)  
  Aziz Nazha, Rami S Komrokji, Andrew Sochacki, Mikkael A Sekeres, Prithviraj Bose, Courtney D DiNardo, Hagop M Kantarjian, Srdan Verstovsek, Sanam Loghavi, Jaroslaw P M..., Blood

Abstracts/Posters

• Preliminary Results from a Phase II Study of the Combination of Pevonedistat and Azacitidine in the Treatment of MDS and MDS/MPN after Failure of DNA Methyltransferase...
  Andrew Sochacki, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Next generation myelofibrosis risk analysis in the electronic health record.
  Andrew L. Sochacki, Cosmin Adrian Bejan, Shilin Zhao, Travis Spaulding, Thomas Stricker, Yaomin Xu, Michael R. Savona, American Society of Hematology Annual Meeting, San Diego, California, 12/2018
• Identification of myelofibrosis from electronic health records with novel algorithms and JAKextractor.
  Cosmin Adrian Bejan, Andrew Sochacki, Shilin Zhao, Yaomin Xu, Michael Savona, Proceedings of the Annual Meeting of the American Association for Cancer Research, Chicago, Illinois, 4/2018
• Preliminary Results from a Phase I Dose Escalation Trial of Ruxolitinib and the PI3Kδ Inhibitor TGR-1202 in Myelofibrosis.
  Tamara K Moyo*, Andrew Sochacki*, Gregory D Ayers, Michael T. Byrne, Stephen A. Strickland, Sanjay R. Mohan, Jill Harrison, Lynne D Berry, Channing V Dudley, Rachel Se..., American Society of Hematology Annual Meeting, San Diego, California, 12/2017
• Join now to see all

Lectures

• Patient Specific Comorbidities Impact Overall Survival in Myelofibrosis 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019